Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R.
Int J Mol Sci. 2021 May 29;22(11):5850. doi: 10.3390/ijms22115850.
Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations.
Goetsch Weisman A, Weiss McQuaid S, Radtke HB, Stoll J, Brown B, Gomes A.
Am J Med Genet A. 2023 Oct;191(10):2467-2481. doi: 10.1002/ajmg.a.63346. Epub 2023 Jul 24.
Neurofibromatosis.
Korf BR.
Handb Clin Neurol. 2013;111:333-40. doi: 10.1016/B978-0-444-52891-9.00039-7.
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R.
Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31.
Living with neurofibromatosis.
Murphy L, Andrawis M, Beatty P, Costa Blasco M, Doyle C, McFeely O, O'Mahony S, Wolinska A, Connolly M.
Clin Exp Dermatol. 2023 Sep 19;48(10):1192-1193. doi: 10.1093/ced/llad228.
Neurofibromatosis update.
Crawford AH, Schorry EK.
J Pediatr Orthop. 2006 May-Jun;26(3):413-23. doi: 10.1097/01.bpo.0000217719.10728.39.
Neurofibromatosis and a Portrait of 1 in 3000.
Mindrup R, Idoate R.
AMA J Ethics. 2020 Jun 1;22(6):E513-524. doi: 10.1001/amajethics.2020.513.
[Segmental neurofibromatosis].
Wagner G, Meyer V, Sachse MM.
Hautarzt. 2018 Jun;69(6):487-490. doi: 10.1007/s00105-017-4078-1.
Neurofibromatosis: an elephant by another name.
Vernon P.
J Pediatr Health Care. 2000 Sep-Oct;14(5):244-6. doi: 10.1067/mph.2000.109162.
Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.
Perez-Becerril C, Evans DG, Smith MJ.
Hum Mutat. 2021 Oct;42(10):1187-1207. doi: 10.1002/humu.24261. Epub 2021 Jul 29.
